Upgrade to SI Premium - Free Trial

Armata Pharma (ARMP)

4.22 -0.18 (4.09%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/18/26)

Latest Headlines

Form 8-K Armata Pharmaceuticals, For: Sep 14 September 14, 2026 7:12 AM - SEC Filing FDA grants Armata Pharmaceuticals breakthrough therapy status for AP-SA02 September 14, 2026 7:01 AM - StreetInsider Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02 September 14, 2026 7:00 AM - PR NewsWire Armata Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference September 10, 2026 7:00 AM - PR NewsWire Armata Pharmaceuticals publishes phage biology study in molecular journal September 3, 2026 7:01 AM - StreetInsider Armata Pharmaceuticals Announces New Publication That Advances Understanding of Phage Biology to Support Development of Next-Generation Antibacterials September 3, 2026 7:00 AM - PR NewsWire Armata Pharmaceuticals, Inc. (ARMP) Tops Q2 EPS by 17c August 12, 2026 4:47 PM - StreetInsider Form 10-Q Armata Pharmaceuticals, For: Jun 30 August 12, 2026 4:23 PM - SEC Filing Form 8-K Armata Pharmaceuticals, For: Aug 12 August 12, 2026 4:17 PM - SEC Filing Armata Pharmaceuticals Announces Financial Results for the Second Quarter 2026 and Provides a Corporate Update August 12, 2026 4:05 PM - PR NewsWire Form 8-K Armata Pharmaceuticals, For: Jul 20 July 20, 2026 7:13 AM - SEC Filing Form 8-K Armata Pharmaceuticals, For: Jul 17 July 20, 2026 7:13 AM - SEC Filing Armata submits Phase 3 protocol to FDA for bacteriophage drug AP-SA02 July 20, 2026 7:00 AM - StreetInsider Armata Pharmaceuticals Achieves Key Progress Across Clinical, Regulatory and Manufacturing Activities Supporting Planned Phase 3 Initiation of AP-SA02 July 20, 2026 7:00 AM - PR NewsWire Form 4 Armata Pharmaceuticals, For: Jul 10 Filed by: Birx Deborah July 14, 2026 4:19 PM - SEC Filing Form 8-K Armata Pharmaceuticals, For: Jul 13 July 13, 2026 7:12 AM - SEC Filing FDA agrees to Armata's pediatric study plan for AP-SA02 bacteremia drug July 13, 2026 7:00 AM - StreetInsider Armata Pharmaceuticals Receives Agreement from FDA on Initial Pediatric Study Plan for AP-SA02 for the Treatment of Complicated Staphylococcus aureus Bacteremia July 13, 2026 7:00 AM - PR NewsWire Form S-8 Armata Pharmaceuticals, July 13, 2026 6:02 AM - SEC Filing Form 8-K/A Armata Pharmaceuticals, For: Apr 24 June 24, 2026 4:19 PM - SEC Filing Form 8-K Armata Pharmaceuticals, For: Jun 23 June 23, 2026 7:11 AM - SEC Filing Armata gets $2.5M more in DoD funding for bacteriophage drug June 23, 2026 7:01 AM - StreetInsider Armata Pharmaceuticals Receives $2.5 Million of Additional Non-Dilutive Award Funding from the U.S. Department of Defense to Support AP-SA02 June 23, 2026 7:00 AM - PR NewsWire Full Article List